PA0787
Model Information:
Metastatic adenocarcinoma in LN, consider originate from pancreas. IHC results: CK(++), CK7(++), CK18(+), CK19(++), CK20(-), CK34(++), CEA(+), CA125(+), CA19-9(+), Ki67(++), AFP(-), Hepatocyte(+/-), Syn(-), Vimentin(-), LCA(+).
| Summary |
|
| Cancer Type |
Pancreatic Cancer |
| Grade |
NA |
| Stage |
NA |
| Ethnicity |
Asian |
| Gender |
F |
| Age |
NA |
| Pathology Diagnosis |
Metastatic adenocarcinoma in LN, consider originate from pancreas. IHC results: CK(++), CK7(++), CK18(+), CK19(++), CK20(-), CK34(++), CEA(+), CA125(+), CA19-9(+), Ki67(++), AFP(-), Hepatocyte(+/-), Syn(-), Vimentin(-), LCA(+). |
| Biopsy Site |
metastatic, LN |
| Treatment History |
NA |
| Pathology QC |
Poorly differentiated adenocarcinoma (Pa, P3). (IHC (P3, P7): TTF1(-), CDX2(+/-),CK7(3+), CK20(3+), CA199(+/-).) |
| Special Features |
NA |
| Mouse Strain |
Balb/c nu |
| TMA |
TMA-HP-PA-018 |
| Viral Status in PDX |
NA |
| Available In |
CB_CN |
| RNA Seq |
P3 |
| Exome Seq |
P4 |
Growth Characteristics
Additional Characteristics
